CVS Reaches $3.8M Settlement In Suit Over Lidocaine Labels
CVS and consumers have agreed to settle for $3.8 million in a New York federal class action over allegations that the pharmacy giant's lidocaine products didn't live up to promises of...To view the full article, register now.
Already a subscriber? Click here to view full article